Webinar: Combining HUB Organoids™ with Organ-on-a-Chip Technology: the Best of Two Worlds

Combining HUB Organoids™ with Organ-on-a-Chip Technology: the Best of Two Worlds

The transition from 2D to 3D cell culture is a first step towards physiologically more relevant in vitro models for human (disease) modeling and preclinical drug development. Organoid and Organ-on-a-Chip technology are two fields of development that are rapidly redefining cell culture biology in the 21st century.

HUB Organoids™ are excellent surrogates of patients, capable of taking on the function of the tissue of origin and modeling a wide range of diseases in the areas of oncology, infectiology, genetics and metabolism.

Organ-on-a-Chip technology has demonstrated how microengineering can add aspects such as perfusion flow, patterning of tissues, extracellular matrix embedment, vascular structure, precise control over gradients and application of mechanical strain to tissue culture.

In this webinar, scientists from MIMETAS and Hubrecht Organoid Technology (HUB) will give you an introduction of HUB Organoids™, and the OrganoPlate® platform. You will learn how a combination of both technologies can be used for in vitro tissue- and disease modeling.

In this webinar you will learn:

  • Why HUB Organoids™ in OrganoPlate® have a great potential for early drug discovery and development
  • Why combining organoids with organ-on-a-chip technology open new doors for (complex) tissue- and disease modelling
  • Which applications combine the best of these two worlds and will inspire your research

Speakers: Robert Vries (HUB) and Kinga Kosim (MIMETAS)

Date: Tuesday, October 13,

Time: 3 PM CET

Register now: Combining HUB Organoids™ with Organ-on-a-Chip Technology: the Best of Two Worlds

 

November 04, 2020 3 Days of 3D Cell Model Virtual Event 2020 Get ready for 3 days of 3D As organoids, spheroids and the study of 3D cell culture models continue to show their potent... read more
September 04, 2020 HUB and BGI-Qingdao sign a Memorandum of Unde... Utrecht and Qingdao, Sep 4th, 2020 – Hubrecht Organoid Technology (HUB) and BGI-Qingdao announced today that they ... read more
May 27, 2020 Studying the development of ovarian cancer wi... read more